Lipid multiparticulate (LMP) technology has the capacity to combine a breadth of functionality with a range of finished dosage formats: capsules, sachets, suspensions and tablets. This technical brief describes Lonza's novel LMP technology, which is based on a proprietary melt-spray-congeal process. This innovative drug delivery approach, which has market precedence, can be used for taste-masking, extended release, and bioavailability enhancement for pharmaceutical, health and nutritional products. To learn more, please read our technical brief.
View our technical brief

Download now
Latest content
Latest briefing from the Knowledge Center